Edition:
United Kingdom

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

7,020JPY
21 Sep 2018
Change (% chg)

¥-10 (-0.14%)
Prev Close
¥7,030
Open
¥7,100
Day's High
¥7,110
Day's Low
¥6,970
Volume
1,205,200
Avg. Vol
778,485
52-wk High
¥7,110
52-wk Low
¥4,550

Summary

Name Age Since Current Position

Osamu Nagayama

70 2018 Chairman of the Board, Representative Director

Tatsuro Kosaka

65 2018 President, Chief Executive Officer, Representative Director

Motoo Ueno

60 2012 Vice Chairman of the Board, Representative Director

Toshiaki Itagaki

2017 Chief Financial Officer, Senior Executive Officer, Director of Finance & Accounting, Senior Manager of IT, Senior Manager of Finance

Junichi Ebihara

2017 Senior Executive Officer, Director of Legal Affairs

Yasushi Ito

2017 Senior Executive Officer, Co-Manager of Project & Lifecycle Management Unit

Susumu Kato

2017 Senior Executive Officer

Keiji Kono

2017 Senior Executive Officer

Hisafumi Okabe

2017 Senior Executive Officer, Chief Director of Translational Clinical Research

Osamu Okuda

2017 Senior Executive Officer, Co-Manager of Project & Lifecycle Management Unit

Shinya Unno

2016 Senior Executive Officer, Senior Manager of Human Resources

Koichi Nishikawa

2017 Executive Officer, Deputy Chief Director of Sales, Director of Overseas Sales Promotion

Tsunanori Sato

Executive Officer, Chief Director of Sales

Shinji Hidaka

2017 Executive Officer, Chief Director of Medical Affairs

Toshihiko Komori

2017 Executive Officer

Hiroyuki Matsumoto

2017 Executive Officer, Senior Manager of South Kanto Office in Main Sales Unit

Hiroshi Murata

2017 Executive Officer, Chief Director of Pharmaceutical Technology

Yoshiaki Ohashi

2017 Executive Officer, Chief Director of Drug Safety, Manager of Regulatory & Quality Assurance Unit

Hisanori Takanashi

2017 Executive Officer, Chief Director of Clinical Development

Minoru Watanabe

2017 Executive Officer, Director of Business Planning

Tetsuya Yamaguchi

2017 Executive Officer, Director of Business Development

Christoph Franz

58 2017 Director

Sophie Kornowski-Bonnet

55 2012 Director

Daniel O'Day

53 2013 Director

Yoichiro Ichimaru

69 2017 Independent Director

Yasuo Ikeda

74 2010 Independent Director

Masayuki Oku

73 2015 Independent Director

Yoko Kitagawa

2017 Manager of Consolidated Accounts Group in Finance & Accounting Unit

Biographies

Name Description

Osamu Nagayama

Mr. Osamu Nagayama has been serving as Chairman of the Board and Representative Director in Chugai Pharmaceutical Co., Ltd. since March 2018. He is also serving as Chairman of the Board of Directors and Independent Director in Sony Corporation. He joined the Company in November 1978. His previous titles include Chief Operating Officer, Chief Executive Officer, President, Deputy Chief Director of Development Planning, Managing Director, Vice President and Director in the Company. He used to work for Long-Term Credit Bank of Japan.

Tatsuro Kosaka

Mr. Tatsuro Kosaka has been serving as President, Chief Executive Officer and Representative Director in Chugai Pharmaceutical Co., Ltd. since March 2018. He is also serving as Independent Director in Asahi Group Holdings, Ltd. He joined the Company in April 1976. His previous titles include Director of Medical Business Strategy, Director of Business Planning, Deputy Chief Senior Director of Sales, Manager of Strategy Marketing Unit, Manager of Life Circle Management and Marketing Unit, Executive Officer, Managing Executive Officer, Senior Managing Executive Officer and Chief Operating Officer in the Company. He used to serve as Vice President in a subsidiary, Chugai Pharma Europe Ltd. (U.K.).

Motoo Ueno

Mr. Motoo Ueno has been serving as Vice Chairman of the Board and Representative Director in Chugai Pharmaceutical Co., Ltd. since March 28, 2012. He joined the Company in April 1984. His previous titles include Chief Director of Learning, Chief Director of Clinical Development, Deputy Chief Senior Director of Research, Managing Director, Managing Executive Officer and Executive Vice President in the Company. He previously served as President and Representative Director in a subsidiary, Chugai Pharma Manufacturing Co., Ltd. He also used to work for SHOWA DENKO K.K.

Toshiaki Itagaki

Junichi Ebihara

Yasushi Ito

Susumu Kato

Keiji Kono

Hisafumi Okabe

Osamu Okuda

Shinya Unno

Koichi Nishikawa

Tsunanori Sato

Shinji Hidaka

Toshihiko Komori

Hiroyuki Matsumoto

Hiroshi Murata

Yoshiaki Ohashi

Hisanori Takanashi

Minoru Watanabe

Tetsuya Yamaguchi

Christoph Franz

Mr. Christoph Franz has been serving as Director in Chugai Pharmaceutical Co., Ltd. since March 2017. He is also serving as Chairman of the Executive Board in its parent company, Roche Holdings Limited, as well as Director in Stadler Rail AG (Switzerland) and Zurich Insurance Group Ltd. (Switzerland). He used to work for Deutsche Lufthansa AG, Deutsche Bahn AG and Swiss International Air Lines AG.

Sophie Kornowski-Bonnet

Ms. Sophie Kornowski-Bonnet has been serving as Director in Chugai Pharmaceutical Co., Ltd. since March 2012. She is also serving as Head of Roche Partnering and Member of the Roche Enlarged Corporate Executive Committee in its parent company, Roche Holding Ltd. She used to work for Abbott Diagnostic Division, France, Abbott Pharmaceutical Products, U.S.A., Sanofi Winthrop, U.S.A., Sanofi Winthrop, France, Merck Sharp & Dohme, France, Merck Sharp & Dohme Israel, Merck & Co. Inc. U.S.A. and Roche Pharma, France.

Daniel O'Day

Mr. Daniel O'Day has been serving as Director in Chugai Pharmaceutical Co., Ltd. since March 2013. He is also serving as Chief Executive Officer of Roche Pharmaceuticals and Member of the Corporate Executive Committee in its parent company, Roche Holding Ltd., as well as Director in Genentech (USA). He used to work for Roche Pharma U.S.A., Roche Pharma Japan, Roche Pharma Denmark and Roche Molecular Diagnostics.

Yoichiro Ichimaru

Mr. Yoichiro Ichimaru has been serving as Independent Director in Chugai Pharmaceutical Co., Ltd. since March 2017. He is also working for Toyota Motor Corporation and Aioi Nissay Dowa Insurance Co., Ltd. He used to work for Toyota Motor Sales Co., Ltd. and Aioi Insurance Co., Ltd.

Yasuo Ikeda

Mr. Yasuo Ikeda has been serving as Independent Director in Chugai Pharmaceutical Co., Ltd. since March 2010. He is also a Professor Emeritus of Keio University, and a Specially Appointed Professor of Waseda University. He is also working for Musashi Academy of the Nezu Foundation, The Tokyo Biochemical Research Foundation, Senshin Medical Research Foundation, Foundation for Promotion of Medical Training, The Naito Foundation, The Japanese Association of Medical Sciences, Foundation for Biomedical Research and Innovation at Kobe and The Japanese Society on Thrombosis and Homeostasis.

Masayuki Oku

Mr. Masayuki Oku has been serving as Independent Director in Chugai Pharmaceutical Co., Ltd. since March 2015. He is also serving as Independent Director in Kao Corporation, Komatsu Ltd. and Panasonic Corporation, as well as Non-Executive Director in The Bank of East Asia (China) Ltd., and working for Sumitomo Mitsui Financial Group, Inc. and Nankai Electric Railway Co., Ltd. He used to work for The Sumitomo Bank, Ltd.

Yoko Kitagawa